163 related articles for article (PubMed ID: 1766001)
1. Immunostimulation by a partially modified retro-inverso-tuftsin analogue containing Thr1 psi[NHCO](R,S)Lys2 modification.
Verdini AS; Silvestri S; Becherucci C; Longobardi MG; Parente L; Peppoloni S; Perretti M; Pileri P; Pinori M; Viscomi GC
J Med Chem; 1991 Dec; 34(12):3372-9. PubMed ID: 1766001
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory effect of tuftsin and its retro-inverso analogue in rat adjuvant arthritis.
Becherucci C; Perretti M; Nencioni L; Silvestri S; Parente L
Agents Actions; 1992; Spec No():C115-7. PubMed ID: 1442329
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and functional studies of tuftsin analogs containing isopeptide bond.
Mezö G; Szekerke M; Sármay G; Gergely J
Peptides; 1990; 11(3):405-15. PubMed ID: 2381868
[TBL] [Abstract][Full Text] [Related]
4. Effect of partially modified retro-inverso analogues derived from C-reactive protein on the induction of nitric oxide synthesis in peritoneal macrophages.
Arcoleo F; Milano S; D'Agostino P; Misiano G; Cappelletti S; Gromo G; Marcucci F; Leoni F; Cillari E
Br J Pharmacol; 1997 Apr; 120(7):1383-9. PubMed ID: 9105716
[TBL] [Abstract][Full Text] [Related]
5. Effect of tuftsin and its retro-inverso analogue on the release of interferon (IFN-gamma) and tumor necrosis factor (TNF-alpha) by human leucocytes.
Paulesu L; Di Stefano A; Luzzi E; Bocci V; Silvestri S; Nencioni L
Immunol Lett; 1992 Sep; 34(1):7-11. PubMed ID: 1478707
[TBL] [Abstract][Full Text] [Related]
6. In vivo immunopharmacological properties of tuftsin and four analogs.
Kraus-Berthier L; Rémond G; Visalli M; Héno D; Portevin B; Vincent M
Immunopharmacology; 1993; 25(3):261-7. PubMed ID: 8354642
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activity of [L-hydroxyproline]3-tuftsin analogue and its alpha- or beta-O-D-glucosylated derivatives.
Biondi L; Filira F; Rocchi R; Tzehoval E; Fridkin M
Int J Pept Protein Res; 1993 Jan; 41(1):43-51. PubMed ID: 8436445
[TBL] [Abstract][Full Text] [Related]
8. H-Gly-His psi (NHCO)Lys-OH, partially modified retro-inverso analogue of the growth factor glycyl-L-histidyl-L-lysine with enhanced enzymatic stability.
Dalpozzo A; Kanai K; Kereszturi G; Calabrese G
Int J Pept Protein Res; 1993 Jun; 41(6):561-6. PubMed ID: 8349414
[TBL] [Abstract][Full Text] [Related]
9. The generation of antibody in mice to tuftsin: a naturally occurring phagocytosis stimulating tetrapeptide.
Naim JO; van Oss CJ
Immunol Invest; 1991 Jul; 20(4):351-64. PubMed ID: 1937582
[TBL] [Abstract][Full Text] [Related]
10. Cross-reactivity of antibodies to retro-inverso peptidomimetics with the parent protein histone H3 and chromatin core particle. Specificity and kinetic rate-constant measurements.
Benkirane N; Guichard G; Van Regenmortel MH; Briand JP; Muller S
J Biol Chem; 1995 May; 270(20):11921-6. PubMed ID: 7744843
[TBL] [Abstract][Full Text] [Related]
11. The immunomodulatory activity of tetra- and tripeptides of tuftsin-kentsin group.
Wieczorek Z; Zimecki M; Słoń JJ; Siemion IZ
Peptides; 1994; 15(2):215-21. PubMed ID: 8008626
[TBL] [Abstract][Full Text] [Related]
12. In vivo immunopharmacological properties of tuftsin (Thr-Lys-Pro-Arg) and some analogues.
Florentin I; Chung V; Martinez J; Maral J; Le Garrec Y; Mathé G
Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):73-80. PubMed ID: 2423822
[TBL] [Abstract][Full Text] [Related]
13. Competition between tuftsin and HBV S-protein sequences.
Siemion IZ; Słoń J; Nawrocka E; Wieczorek Z
Int J Pept Protein Res; 1990 May; 35(5):428-33. PubMed ID: 2376468
[TBL] [Abstract][Full Text] [Related]
14. Polytuftsin: a potential precursor for slow release of the phagocytosis stimulating peptide tuftsin.
Surkis R; Rubinraut S; Dagan S; Tzehoval E; Fridkin M; Ben Yoseph R; Catane R
Int J Biochem; 1990; 22(2):193-5. PubMed ID: 2332102
[TBL] [Abstract][Full Text] [Related]
15. Glyco-tuftsin derivatives modulate interleukin-1 and tumor necrosis factor production.
Rocchi R; Biondi L; Filira F; Tzehoval E; Dagan S; Fridkin M
Int J Pept Protein Res; 1991 Mar; 37(3):161-6. PubMed ID: 1869367
[TBL] [Abstract][Full Text] [Related]
16. Enhanced phagocytosis activity of cyclic analogs of tuftsin.
Nishioka K; Obeyesekere NU; McMurray JS
Biochem Pharmacol; 1995 Mar; 49(5):735-8. PubMed ID: 7887989
[TBL] [Abstract][Full Text] [Related]
17. Tuftsin, a natural activator of phagocytic functions including tumoricidal activity.
Najjar VA; Konopinska D; Chaudhuri MK; Schmidt DE; Linehan L
Mol Cell Biochem; 1981 Dec; 41():3-12. PubMed ID: 6895774
[TBL] [Abstract][Full Text] [Related]
18. Analysis of a bioactive synthetic analogue of tuftsin by tandem mass spectrometry: anomalous fast atom bombardment activated processes.
De Angelis F; Nicoletti R; Kuster T; Heizmann CW; Pinori M; Verdini AS
Biol Mass Spectrom; 1994 May; 23(5):262-6. PubMed ID: 8204682
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological activity of tuftsin and rigin derivatives containing monosaccharides or monosaccharide derivatives.
Rocchi R; Biondi L; Cavaggion F; Filira F; Gobbo M; Dagan S; Fridkin M
Int J Pept Protein Res; 1987 Feb; 29(2):262-75. PubMed ID: 3570666
[TBL] [Abstract][Full Text] [Related]
20. Further investigations on the antinociceptive activity of tuftsin analogs.
Nawrocka-Bolewska E; Kubik A; Szewczuk Z; Siemion IZ; Obuchowicz E; Gołba K; Herman ZS
Pol J Pharmacol Pharm; 1991; 43(4):281-8. PubMed ID: 1811220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
